Lazarus Pharmaceuticals does not build weapons. The LP-3 is a medical compliance enforcement platform. That is the official position, and Lazarus's legal department has defended it in seventeen separate Meridian Quorum hearings. The LP-3 is a four-legged platform the size of a large dog, equipped with hypodermic injection systems, restraint clamps, and a pharmacy bay capable of carrying eight doses of various pharmaceutical agents. Its designated purpose is the safe restraint and involuntary medication of patients in psychiatric crisis, quarantine enforcement, and medical debt collection — yes, collection.

In practice, the LP-3 chases people down and injects them with whatever its pharmacy bay has been loaded with. The restraint clamps lock around limbs with hydraulic force sufficient to immobilize augmented individuals. The hypodermic system can deliver intramuscular injections through clothing and light armor. Lazarus deploys them in medical facilities, pharmaceutical distribution centers, and — most controversially — in the field during what Lazarus terms 'community health operations' that look indistinguishable from raids.

The LP-3's most disturbing operational mode is 'persistent compliance,' in which the unit follows a designated individual at a fixed distance, injecting them on a schedule, for as long as its pharmacy bay holds doses. This mode was designed for outpatient psychiatric medication compliance. It has been documented in use against medical debt holders, corporate whistleblowers, and union organizers, loaded with sedatives or disorienting agents rather than therapeutic medications.